TMOD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.837400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.631800E-01
Normal-vs-Stage2
3.123400E-01
Normal-vs-Stage3
8.260600E-01
Normal-vs-Stage4
2.701400E-01
Stage1-vs-Stage2
7.342200E-01
Stage1-vs-Stage3
3.500200E-01
Stage1-vs-Stage4
5.100000E-01
Stage2-vs-Stage3
1.608970E-01
Stage2-vs-Stage4
5.353800E-01
Stage3-vs-Stage4
2.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.859400E-01
Normal-vs-AfricanAmerican
5.015600E-01
Normal-vs-Asian
6.479600E-01
Caucasian-vs-AfricanAmerican
7.757600E-01
Caucasian-vs-Asian
4.003400E-01
AfricanAmerican-vs-Asian
7.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.970000E-01
Normal-vs-Female
3.805000E-01
Male-vs-Female
8.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.053000E-01
Normal-vs-Age(41-60Yrs)
1.965000E-01
Normal-vs-Age(61-80Yrs)
4.998000E-01
Normal-vs-Age(81-100Yrs)
5.765000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.185600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.234600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.960200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.736800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.150000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.402800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.923600E-01
Normal-vs-Daily Drinker
6.221400E-01
Normal-vs-Weekly Drinker
6.985000E-01
Normal-vs-Occasional Drinker
3.484800E-01
Normal-vs-Social Drinker
4.327200E-01
Non Drinker-vs-Daily Drinker
4.520400E-01
Non Drinker-vs-Weekly Drinker
2.629600E-01
Non Drinker-vs-Occasional Drinker
6.524200E-01
Non Drinker-vs-Social Drinker
3.634800E-01
Daily Drinker-vs-Weekly Drinker
6.880800E-01
Daily Drinker-vs-Occasional Drinker
2.983800E-01
Daily Drinker-vs-Social Drinker
9.807400E-01
Weekly Drinker-vs-Occasional Drinker
1.781580E-01
Weekly Drinker-vs-Social Drinker
6.294800E-01
Occasional Drinker-vs-Social Drinker
2.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.610370E-01
Normal-vs-Grade 2
7.399300E-03
Normal-vs-Grade 3
1.268020E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.920540E-03
Grade 1-vs-Grade 3
2.578400E-04
Grade 1-vs-Grade 4
1.610370E-01
Grade 2-vs-Grade 3
5.330100E-02
Grade 2-vs-Grade 4
7.399300E-03
Grade 3-vs-Grade 4
1.268020E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.045600E-01
Normal-vs-NonDiabetic
3.805800E-01
Diabetic-vs-NonDiabetic
1.997220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.919200E-01
Normal-vs-NoPancreatitis
4.131000E-01
Pancreatitis-vs-NoPancreatitis
9.391200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.559400E-01
Normal-vs-N1
2.867000E-01
N0-vs-N1
9.280000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.207380E-01
Normal-vs-TP53-NonMutant
7.594200E-01
TP53-Mutant-vs-TP53-NonMutant
1.41129999997602E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
